Turkish and Middle Eastern healthcare industries have a dynamic and variable structure in terms of both their service providers and official approval authority structure. This structure in the emerging markets includes various opportunities and threats for local and foreign companies willing to make investments. With the power of knowledge, we provide access to multidisciplinary markets and business development consultancy in the regions we live and we have experience in, we determine the real value and capabilities of your drug and production facility with concrete data over the local dynamics, and we guide you to reach the target drugs and markets in the relevant countries.

• Rheumatology

• Immunology

• Inherited Metabolic Diseases

• Rare Diseases

• Cardiology

• Neurology and Neurosurgery

• Oncology

• Haematology

• Orthopaedics

• Dermatology

• Plastic Surgery